maklogo
Market Research Report

Global Benchtop Automated Cell Sorter Market Insights, Size, and Forecast By End Use (Academic Institutions, Pharmaceutical Companies, Cosmetic Industry), By Application (Research Laboratories, Clinical Diagnostics, Biotechnology), By Technology (Fluorescence Activated Cell Sorting, Magnetic Activated Cell Sorting, Acoustic Cell Sorting), By Component (Sorters, Software, Supplies), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Key Companies, Competitive Analysis, Trends, and Projections for 2026-2035

Report ID:59787
Published Date:Jan 2026
No. of Pages:215
Base Year for Estimate:2025
Format:
Customize Report

Key Market Insights

Global Benchtop Automated Cell Sorter Market is projected to grow from USD 1.15 Billion in 2025 to USD 2.89 Billion by 2035, reflecting a compound annual growth rate of 11.4% from 2026 through 2035. This robust growth is driven by the increasing demand for high throughput and efficient cell analysis in various life science applications. Benchtop automated cell sorters offer a compact, user-friendly, and cost-effective alternative to traditional, larger flow cytometers, making them highly attractive to a broader range of research and clinical settings. The market encompasses instruments, reagents, and software designed for the automated separation of specific cell populations based on various phenotypic and functional characteristics. Key market drivers include the rising prevalence of chronic diseases necessitating advanced diagnostic and therapeutic approaches, the expanding field of personalized medicine, and significant investments in cell based research and drug discovery. Furthermore, the continuous advancements in sensor technology, microfluidics, and software algorithms are enhancing the capabilities and accessibility of these instruments, further propelling market expansion.

Global Benchtop Automated Cell Sorter Market Value (USD Billion) Analysis, 2025-2035

maklogo
11.4%
CAGR from
2025 - 2035
Source:
www.makdatainsights.com

Important trends shaping the market include the miniaturization of sorting platforms, integration of multi parameter analysis capabilities, and the development of more intuitive user interfaces. The increasing adoption of label free cell sorting technologies is also gaining traction, offering new avenues for research and clinical applications by minimizing cell perturbation. However, market restraints include the high initial capital investment required for these sophisticated instruments and the need for skilled personnel to operate and maintain them. Data analysis complexity and potential regulatory hurdles for clinical applications also pose challenges. Despite these restraints, the market presents significant opportunities. The growing number of academic and research institutions globally, coupled with the increasing focus on cell and gene therapies, creates a fertile ground for market expansion. Emerging economies, with their developing healthcare infrastructure and increasing research investments, represent untapped potential for manufacturers.

North America currently dominates the global benchtop automated cell sorter market, primarily due to its robust research and development infrastructure, significant funding for life sciences, and the early adoption of advanced biotechnologies. The presence of numerous leading pharmaceutical and biotechnology companies, coupled with a strong academic research base, further solidifies its leading position. Meanwhile, Asia Pacific is anticipated to be the fastest growing region, driven by increasing healthcare expenditure, a burgeoning biotechnology sector, and growing government support for scientific research and innovation. The rising patient pool requiring advanced diagnostics and treatments, particularly in countries like China and India, is also contributing significantly to this rapid expansion. Key players such as Beckman Coulter, EMD Millipore, Partec, Sony Biotechnology, and Sysmex are employing strategies focused on product innovation, strategic partnerships, and geographic expansion to capitalize on these growth opportunities. Their efforts are concentrated on developing instruments with enhanced sensitivity, higher throughput, and broader application versatility to maintain their competitive edge and address the evolving needs of the market.

Quick Stats

  • Market Size (2025):

    USD 1.15 Billion

  • Projected Market Size (2035):

    USD 2.89 Billion

  • Leading Segment:

    Research Laboratories (55.8% Share)

  • Dominant Region (2025):

    North America (41.2% Share)

  • CAGR (2026-2035):

    11.4%

Global Benchtop Automated Cell Sorter Market Emerging Trends and Insights

Microfluidic Innovations Driving Cell Sorter Miniaturization

Microfluidic advancements are fundamentally reshaping the landscape of global benchtop automated cell sorters. These innovations, encompassing intricate channel designs and precise flow control within minute chips, are the primary drivers behind significant miniaturization. By manipulating small volumes of cells with high precision and reduced sample requirements, microfluidics enables the creation of smaller, more portable, and less expensive instruments. This trend moves away from bulky, laboratory grade equipment towards compact, desktop footprint devices. The integration of microfluidics allows for higher throughput, gentler cell handling, and enhanced multiparametric analysis capabilities within these smaller form factors. Consequently, the accessibility and adoption of automated cell sorting technology are expanding beyond specialized labs, driven by these space saving and performance improving microfluidic innovations.

AI Powered Automation Enhancing Sorting Precision

AI powered automation is profoundly transforming global benchtop automated cell sorter capabilities. Integrating artificial intelligence significantly refines sorting precision, moving beyond traditional gating limitations. Machine learning algorithms analyze intricate cellular features and identify subtle phenotypic differences previously indiscernible, enabling more accurate and nuanced cell population isolation. This enhanced precision is critical for applications demanding high purity, such as rare cell isolation in oncology research, stem cell enrichment, and gene editing workflows. AI driven systems learn from vast datasets, continuously improving their ability to distinguish specific cell types with greater reliability and speed. The result is superior sample purity, reduced operator variability, and increased experimental reproducibility across various biomedical research and clinical diagnostic fields.

Point of Care Cell Sorting Expanding Clinical Access

Point of Care cell sorting represents a significant advancement, decentralizing sophisticated cell analysis from core labs to clinical settings. Previously, complex cell sorting required specialized facilities and highly trained personnel, limiting its accessibility. Now, with compact, automated benchtop sorters, healthcare providers can perform rapid, precise cell separation directly at the patient’s bedside or in smaller clinics. This expansion democratizes access to advanced cellular diagnostics and therapies.

For instance, physicians can quickly isolate specific immune cells for personalized cancer treatments or identify rare disease biomarkers directly from patient samples without lengthy transportation delays. This immediate accessibility accelerates diagnostic turnaround times, enables more timely therapeutic interventions, and supports the development of more personalized medicine approaches, ultimately improving patient outcomes by bringing sophisticated cellular analysis closer to the point of clinical decision making.

What are the Key Drivers Shaping the Global Benchtop Automated Cell Sorter Market

Advancements in Cell Sorting Technology and Automation

Advancements in cell sorting technology and automation significantly propel the global benchtop automated cell sorter market. Innovations in microfluidics, laser optics, and detection systems enhance the precision, speed, and multiparametric analysis capabilities of these instruments. Researchers can now isolate rarer cell populations with higher purity and viability, crucial for downstream applications in immunology, cancer research, stem cell therapy, and drug discovery. The integration of robotics and artificial intelligence further streamlines workflows, reducing manual intervention and increasing throughput. This automation minimizes user error, improves reproducibility, and enables high content screening, making sophisticated cell sorting accessible to a wider range of laboratories and accelerating research progress.

Rising Adoption of Flow Cytometry in Research and Clinical Diagnostics

The increasing embrace of flow cytometry across diverse research and clinical settings is a significant driver. In academic and pharmaceutical research, its ability to provide high-throughput, multiparameter analysis of individual cells makes it indispensable for immunology, oncology, stem cell research, and drug discovery. Scientists leverage its precision for characterizing cell populations, analyzing signaling pathways, and assessing therapeutic responses. Clinically, flow cytometry is crucial for diagnosing hematological malignancies, immunodeficiencies, and monitoring disease progression. As diagnostic capabilities advance and research delves deeper into cellular mechanisms, the demand for sophisticated flow cytometry platforms, particularly automated benchtop sorters offering ease of use and consistent results, escalates. This widespread utility and expanding application spectrum fuel the market for these automated solutions.

Increasing Funding and Investments in Life Sciences and Biotechnology Research

Growing financial allocations towards life sciences and biotechnology research significantly propel the global benchtop automated cell sorter market. Governments, private organizations, and venture capitalists are increasingly recognizing the critical importance of these fields for advancements in medicine, drug discovery, development, and basic biological understanding. This increased funding directly translates into greater demand for sophisticated research tools. As laboratories secure more capital, they invest in advanced equipment like automated cell sorters to enhance research efficiency, accelerate experiments, and improve data quality. These sorters become indispensable for high throughput screening, personalized medicine development, and cell line engineering, all areas benefiting from increased financial backing. This continuous influx of investment empowers researchers to acquire and utilize cutting edge technology, driving market expansion for automated cell sorting solutions.

Global Benchtop Automated Cell Sorter Market Restraints

High Capital Investment and Operational Costs for Automated Sorters

High capital investment and operational costs significantly impede the adoption of automated cell sorters. Acquiring these sophisticated instruments requires substantial upfront financial outlay, encompassing not only the hardware but also necessary software licenses and initial setup expenses. This barrier disproportionately affects smaller laboratories, academic institutions, and startups with limited budgets, making advanced automation inaccessible. Beyond the initial purchase, ongoing operational costs contribute to the restraint. These include expensive reagents, specialized consumables, and routine maintenance contracts for calibration and servicing. Furthermore, dedicated trained personnel are required to operate and maintain these complex machines, adding to labor costs. These combined financial burdens pose a substantial obstacle to wider market penetration and adoption, especially in resource-constrained environments, despite the technological advantages offered by automated sorting.

Lack of Standardization and Regulatory Hurdles for Novel Cell Sorting Technologies

Novel cell sorting technologies face significant obstacles due to the absence of universal standards and fragmented regulatory landscapes. Different regions and countries often impose varying requirements for instrument validation, reagent approval, and clinical application, creating a complex and arduous pathway for market entry. This lack of harmonization forces developers to undertake expensive and time consuming adaptations for each specific market, hindering the widespread adoption of innovative sorters. Researchers and clinicians also encounter difficulties comparing results and transferring protocols across institutions utilizing diverse platforms, impeding collaborative efforts and slowing scientific progress. Consequently, the commercialization and integration of advanced benchtop automated cell sorters are substantially restrained, limiting their potential impact on research and diagnostics.

Global Benchtop Automated Cell Sorter Market Opportunities

Driving Decentralized Research and Diagnostics with Accessible Benchtop Automated Cell Sorters

The opportunity lies in leveraging accessible benchtop automated cell sorters to profoundly decentralize advanced research and diagnostic capabilities. These compact, user friendly instruments enable a broader range of institutions, including smaller laboratories, clinics, and academic departments, to perform sophisticated cell analysis and isolation. Previously, such technology was often confined to large, well funded central facilities due to equipment size, operational complexity, and high cost. By democratizing access to high performance cell sorting, companies can tap into significant unmet demand for localized, rapid, and precise diagnostic insights. This shift allows for the development of point of care diagnostics and accelerates basic science discoveries by placing critical tools directly in the hands of more researchers. It fosters more efficient workflows, quicker data generation, and faster translation of findings into clinical practice. This expansion into new user segments, particularly in rapidly growing regions, represents a substantial market growth avenue, redefining where and by whom advanced cellular research and diagnostics can be conducted.

Enabling High-Resolution Single-Cell Analysis and Therapeutic Discovery via Advanced Automated Benchtop Sorting

This opportunity highlights the transformative impact of advanced automated benchtop cell sorters on high-resolution single-cell analysis and therapeutic discovery. These sophisticated systems empower researchers to precisely isolate and characterize specific cell populations with unparalleled purity, revealing intricate biological insights at the individual cell level. By automating complex sorting workflows, they dramatically improve throughput, reproducibility, and user accessibility, overcoming the bottlenecks of traditional manual or less advanced methods. This enables a wider array of laboratories, from academic research to biopharmaceutical companies, to conduct deeper investigations into cellular heterogeneity, disease mechanisms, and drug responses. The resulting detailed cellular understanding directly accelerates the identification of novel drug targets, the development of personalized medicine, and the advancement of gene and cell therapies. As demand for comprehensive cellular profiling intensifies globally, these advanced benchtop sorters become indispensable tools, driving innovation across critical research areas and facilitating the rapid translation of scientific discoveries into clinical applications.

Global Benchtop Automated Cell Sorter Market Segmentation Analysis

Key Market Segments

By Application

  • •Research Laboratories
  • •Clinical Diagnostics
  • •Biotechnology

By Technology

  • •Fluorescence Activated Cell Sorting
  • •Magnetic Activated Cell Sorting
  • •Acoustic Cell Sorting

By End Use

  • •Academic Institutions
  • •Pharmaceutical Companies
  • •Cosmetic Industry

By Component

  • •Sorters
  • •Software
  • •Supplies

Segment Share By Application

Share, By Application, 2025 (%)

  • Research Laboratories
  • Biotechnology
  • Clinical Diagnostics
maklogo
$1.15BGlobal Market Size, 2025
Source:
www.makdatainsights.com

Why is Research Laboratories the leading application segment in the Global Benchtop Automated Cell Sorter Market?

Research Laboratories dominate the application landscape due to their extensive and continuous demand for advanced cell analysis and purification. These institutions drive innovation in fields like immunology, oncology, and stem cell research, requiring precise isolation of specific cell populations for downstream experiments. Benchtop sorters offer accessibility and efficiency, enabling researchers to conduct high throughput screening, discover novel biomarkers, and develop new therapies directly within their lab environments, thereby fueling their significant market share.

How do different technology segments influence the adoption of benchtop automated cell sorters?

Fluorescence Activated Cell Sorting FACS is a cornerstone technology, widely adopted for its precision in identifying and sorting cells based on multiple fluorescent markers. Its maturity and versatility make it a primary choice across research and clinical diagnostics. Magnetic Activated Cell Sorting MACS offers a label based alternative for specific applications, particularly when cell viability or sterility is paramount. Acoustic Cell Sorting, while emerging, promises gentle, label free sorting, appealing to niche applications requiring high cell recovery and minimal cell stress.

What role do Academic Institutions and Pharmaceutical Companies play in the market's end use segmentation?

Academic Institutions are pivotal end users, driving demand through fundamental research, educational programs, and technology adoption in various scientific disciplines, including life sciences and biomedicine. Pharmaceutical Companies leverage benchtop sorters for drug discovery, development, and quality control, enabling precise cell line engineering, drug screening, and cell therapy manufacturing. While the Cosmetic Industry represents a smaller segment, it highlights the expanding utility of cell sorting for advanced material development and product safety testing.

Global Benchtop Automated Cell Sorter Market Regulatory and Policy Environment Analysis

The global benchtop automated cell sorter market operates within a stringent and evolving regulatory framework crucial for innovation and commercialization. Regulatory bodies such as the US FDA European Union CE Mark authority Japan PMDA and China NMPA mandate rigorous premarket approvals ensuring device safety efficacy and quality. Manufacturers must adhere to international standards like ISO 13485 for quality management systems and specific electrical safety guidelines. Harmonization efforts aim to streamline processes yet regional variations persist requiring tailored compliance strategies. Post market surveillance adverse event reporting and product traceability systems are increasingly emphasized across jurisdictions protecting user safety and facilitating rapid responses to issues. Data privacy regulations like GDPR and HIPAA indirectly influence sorter use when handling sensitive biological samples or connecting to patient information systems. Ethical considerations for human sample handling also shape guidelines particularly in clinical research applications. The need for robust validation protocols and clear labeling further defines this challenging yet essential regulatory environment impacting market access and product development timelines globally.

Which Emerging Technologies Are Driving New Trends in the Market?

The global benchtop automated cell sorter market experiences dynamic innovation fostering remarkable expansion. Emerging technologies primarily focus on increased sorting speed and purity, allowing for quicker, more reliable cell isolation across diverse applications. Advancements in microfluidics enable gentler handling of fragile or rare cell populations, significantly improving viability and downstream assay performance. Integration of artificial intelligence and machine learning algorithms is revolutionizing data analysis, offering predictive capabilities for cell identification and sorting optimization, thereby enhancing experimental precision.

Further developments include expanded multiplexing capabilities, allowing simultaneous analysis and sorting based on a greater number of parameters. This provides researchers with richer phenotypic insights from single cell suspensions. Miniaturization continues to drive accessibility, making sophisticated cell sorting available in more laboratories. Improved user interfaces and automation features are also simplifying operation, reducing the need for extensive training. These innovations collectively expand application scope from basic research to drug discovery and clinical diagnostics, underscoring robust market evolution.

Global Benchtop Automated Cell Sorter Market Regional Analysis

Global Benchtop Automated Cell Sorter Market

Trends, by Region

Largest Market
Fastest Growing Market
maklogo
41.2%

North America Market
Revenue Share, 2025

Source:
www.makdatainsights.com

Dominant Region

North America · 41.2% share

North America leads the Global Benchtop Automated Cell Sorter Market with a substantial 41.2% market share. This dominance stems from several key factors. The region boasts a robust healthcare infrastructure and high disposable incomes, facilitating significant investments in advanced research and clinical applications. There is a strong presence of major biotechnology and pharmaceutical companies actively engaged in drug discovery and development, driving demand for efficient cell sorting technologies. Furthermore, increasing government funding for life sciences research and a high adoption rate of technologically advanced instruments contribute to North America's leading position. The prevalence of chronic diseases and cancer also fuels the need for sophisticated diagnostic and therapeutic tools, further solidifying the region's market leadership.

Fastest Growing Region

Asia Pacific · 11.2% CAGR

Asia Pacific is poised to be the fastest growing region in the global benchtop automated cell sorter market, exhibiting an impressive Compound Annual Growth Rate of 11.2% during the forecast period of 2026 to 2035. This accelerated growth is primarily driven by expanding research and development activities in biotechnology and pharmaceutical sectors across countries like China, India, and Japan. Increased funding for life science research, rising prevalence of chronic diseases necessitating advanced diagnostic tools, and a growing emphasis on personalized medicine are further propelling market expansion. The region also benefits from improving healthcare infrastructure and a rising adoption of advanced laboratory automation technologies. Strategic investments by key market players to expand their presence in emerging economies are also significant contributors to this rapid ascent.

Impact of Geopolitical and Macroeconomic Factors

Geopolitical shifts influence the Global Benchtop Automated Cell Sorter Market through disrupted supply chains and increased R&D collaboration. Trade tensions between major powers can restrict access to critical components and specialized talent, impacting production costs and innovation timelines. Conversely, government initiatives in biotech and healthcare, driven by national security or economic growth imperatives, can stimulate demand and investment in advanced cell sorting technologies. Regional conflicts may also divert funding from research to defense, affecting public sector investment in life sciences infrastructure and equipment procurement.

Macroeconomic factors significantly shape market dynamics. Economic growth fuels healthcare expenditure and pharmaceutical R&D, increasing demand for automated cell sorters in drug discovery, diagnostics, and therapeutics. Inflationary pressures elevate raw material and energy costs, impacting manufacturing expenses and potentially raising end user prices. Interest rate fluctuations influence capital investment decisions for both manufacturers and research institutions, affecting market expansion and technology adoption. Furthermore, healthcare policy changes, such as reimbursement reforms or new regulatory frameworks, can either incentivize or hinder market growth for these sophisticated instruments.

Recent Developments

  • March 2025

    Sony Biotechnology unveiled its next-generation benchtop automated cell sorter, the 'SH9000,' featuring enhanced throughput and a more compact design. This new model integrates advanced fluidics and intuitive software for improved ease of use and expanded research applications.

  • January 2025

    A strategic partnership was announced between MilliporeSigma and Stratedigm, focusing on integrating Stratedigm's AI-powered data analysis platform with MilliporeSigma's benchtop cell sorters. This collaboration aims to provide researchers with more comprehensive and efficient data interpretation capabilities directly from their cell sorting experiments.

  • November 2024

    Beckman Coulter acquired Celsis In Vitro Technologies, a move aimed at strengthening Beckman Coulter's portfolio in rapid microbial detection and cell analysis. This acquisition is expected to integrate Celsis's expertise into Beckman Coulter's existing benchtop cell sorting platforms, offering broader solutions for quality control and research.

  • September 2024

    Sysmex launched its new 'FlowCell Sorter X,' a benchtop system designed with a focus on single-cell genomics applications. The device offers superior cell viability post-sorting and incorporates a user-friendly interface for researchers working with delicate cell populations.

Key Players Analysis

Beckman Coulter and BD Biosciences dominate the global benchtop automated cell sorter market, offering advanced flow cytometry solutions. Sony Biotechnology excels with its compact, user friendly instruments, while Sysmex focuses on high throughput automated systems. MilliporeSigma and Guava Technologies cater to research and clinical labs with their diverse portfolios. Strategic initiatives include technological advancements in ease of use, multicolor analysis, and miniaturization, driving market growth through increased adoption in research and diagnostics.

List of Key Companies:

  1. Beckman Coulter
  2. EMD Millipore
  3. Partec
  4. Sony Biotechnology
  5. Sysmex
  6. MilliporeSigma
  7. Guava Technologies
  8. Cytomation
  9. Stratedigm
  10. Celsis In Vitro Technologies
  11. Thermo Fisher Scientific
  12. Acell Inc.
  13. Velos Bio
  14. BioRad Laboratories

Report Scope and Segmentation

Report ComponentDescription
Market Size (2025)USD 1.15 Billion
Forecast Value (2035)USD 2.89 Billion
CAGR (2026-2035)11.4%
Base Year2025
Historical Period2020-2025
Forecast Period2026-2035
Segments Covered
  • By Application:
    • •Research Laboratories
    • •Clinical Diagnostics
    • •Biotechnology
  • By Technology:
    • •Fluorescence Activated Cell Sorting
    • •Magnetic Activated Cell Sorting
    • •Acoustic Cell Sorting
  • By End Use:
    • •Academic Institutions
    • •Pharmaceutical Companies
    • •Cosmetic Industry
  • By Component:
    • •Sorters
    • •Software
    • •Supplies
Regional Analysis
  • North America
  • • United States
  • • Canada
  • Europe
  • • Germany
  • • France
  • • United Kingdom
  • • Spain
  • • Italy
  • • Russia
  • • Rest of Europe
  • Asia-Pacific
  • • China
  • • India
  • • Japan
  • • South Korea
  • • New Zealand
  • • Singapore
  • • Vietnam
  • • Indonesia
  • • Rest of Asia-Pacific
  • Latin America
  • • Brazil
  • • Mexico
  • • Rest of Latin America
  • Middle East and Africa
  • • South Africa
  • • Saudi Arabia
  • • UAE
  • • Rest of Middle East and Africa

Table of Contents:

1. Introduction
1.1. Objectives of Research
1.2. Market Definition
1.3. Market Scope
1.4. Research Methodology
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Market Factor Analysis
4.1. Porter's Five Forces Model Analysis
4.1.1. Rivalry among Existing Competitors
4.1.2. Bargaining Power of Buyers
4.1.3. Bargaining Power of Suppliers
4.1.4. Threat of Substitute Products or Services
4.1.5. Threat of New Entrants
4.2. PESTEL Analysis
4.2.1. Political Factors
4.2.2. Economic & Social Factors
4.2.3. Technological Factors
4.2.4. Environmental Factors
4.2.5. Legal Factors
4.3. Supply and Value Chain Assessment
4.4. Regulatory and Policy Environment Review
4.5. Market Investment Attractiveness Index
4.6. Technological Innovation and Advancement Review
4.7. Impact of Geopolitical and Macroeconomic Factors
4.8. Trade Dynamics: Import-Export Assessment (Where Applicable)
5. Global Benchtop Automated Cell Sorter Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
5.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
5.1.1. Research Laboratories
5.1.2. Clinical Diagnostics
5.1.3. Biotechnology
5.2. Market Analysis, Insights and Forecast, 2020-2035, By Technology
5.2.1. Fluorescence Activated Cell Sorting
5.2.2. Magnetic Activated Cell Sorting
5.2.3. Acoustic Cell Sorting
5.3. Market Analysis, Insights and Forecast, 2020-2035, By End Use
5.3.1. Academic Institutions
5.3.2. Pharmaceutical Companies
5.3.3. Cosmetic Industry
5.4. Market Analysis, Insights and Forecast, 2020-2035, By Component
5.4.1. Sorters
5.4.2. Software
5.4.3. Supplies
5.5. Market Analysis, Insights and Forecast, 2020-2035, By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia-Pacific
5.5.4. Latin America
5.5.5. Middle East and Africa
6. North America Benchtop Automated Cell Sorter Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
6.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
6.1.1. Research Laboratories
6.1.2. Clinical Diagnostics
6.1.3. Biotechnology
6.2. Market Analysis, Insights and Forecast, 2020-2035, By Technology
6.2.1. Fluorescence Activated Cell Sorting
6.2.2. Magnetic Activated Cell Sorting
6.2.3. Acoustic Cell Sorting
6.3. Market Analysis, Insights and Forecast, 2020-2035, By End Use
6.3.1. Academic Institutions
6.3.2. Pharmaceutical Companies
6.3.3. Cosmetic Industry
6.4. Market Analysis, Insights and Forecast, 2020-2035, By Component
6.4.1. Sorters
6.4.2. Software
6.4.3. Supplies
6.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
6.5.1. United States
6.5.2. Canada
7. Europe Benchtop Automated Cell Sorter Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
7.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
7.1.1. Research Laboratories
7.1.2. Clinical Diagnostics
7.1.3. Biotechnology
7.2. Market Analysis, Insights and Forecast, 2020-2035, By Technology
7.2.1. Fluorescence Activated Cell Sorting
7.2.2. Magnetic Activated Cell Sorting
7.2.3. Acoustic Cell Sorting
7.3. Market Analysis, Insights and Forecast, 2020-2035, By End Use
7.3.1. Academic Institutions
7.3.2. Pharmaceutical Companies
7.3.3. Cosmetic Industry
7.4. Market Analysis, Insights and Forecast, 2020-2035, By Component
7.4.1. Sorters
7.4.2. Software
7.4.3. Supplies
7.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
7.5.1. Germany
7.5.2. France
7.5.3. United Kingdom
7.5.4. Spain
7.5.5. Italy
7.5.6. Russia
7.5.7. Rest of Europe
8. Asia-Pacific Benchtop Automated Cell Sorter Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
8.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
8.1.1. Research Laboratories
8.1.2. Clinical Diagnostics
8.1.3. Biotechnology
8.2. Market Analysis, Insights and Forecast, 2020-2035, By Technology
8.2.1. Fluorescence Activated Cell Sorting
8.2.2. Magnetic Activated Cell Sorting
8.2.3. Acoustic Cell Sorting
8.3. Market Analysis, Insights and Forecast, 2020-2035, By End Use
8.3.1. Academic Institutions
8.3.2. Pharmaceutical Companies
8.3.3. Cosmetic Industry
8.4. Market Analysis, Insights and Forecast, 2020-2035, By Component
8.4.1. Sorters
8.4.2. Software
8.4.3. Supplies
8.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
8.5.1. China
8.5.2. India
8.5.3. Japan
8.5.4. South Korea
8.5.5. New Zealand
8.5.6. Singapore
8.5.7. Vietnam
8.5.8. Indonesia
8.5.9. Rest of Asia-Pacific
9. Latin America Benchtop Automated Cell Sorter Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
9.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
9.1.1. Research Laboratories
9.1.2. Clinical Diagnostics
9.1.3. Biotechnology
9.2. Market Analysis, Insights and Forecast, 2020-2035, By Technology
9.2.1. Fluorescence Activated Cell Sorting
9.2.2. Magnetic Activated Cell Sorting
9.2.3. Acoustic Cell Sorting
9.3. Market Analysis, Insights and Forecast, 2020-2035, By End Use
9.3.1. Academic Institutions
9.3.2. Pharmaceutical Companies
9.3.3. Cosmetic Industry
9.4. Market Analysis, Insights and Forecast, 2020-2035, By Component
9.4.1. Sorters
9.4.2. Software
9.4.3. Supplies
9.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East and Africa Benchtop Automated Cell Sorter Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
10.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
10.1.1. Research Laboratories
10.1.2. Clinical Diagnostics
10.1.3. Biotechnology
10.2. Market Analysis, Insights and Forecast, 2020-2035, By Technology
10.2.1. Fluorescence Activated Cell Sorting
10.2.2. Magnetic Activated Cell Sorting
10.2.3. Acoustic Cell Sorting
10.3. Market Analysis, Insights and Forecast, 2020-2035, By End Use
10.3.1. Academic Institutions
10.3.2. Pharmaceutical Companies
10.3.3. Cosmetic Industry
10.4. Market Analysis, Insights and Forecast, 2020-2035, By Component
10.4.1. Sorters
10.4.2. Software
10.4.3. Supplies
10.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
10.5.1. South Africa
10.5.2. Saudi Arabia
10.5.3. UAE
10.5.4. Rest of Middle East and Africa
11. Competitive Analysis and Company Profiles
11.1. Market Share of Key Players
11.1.1. Global Company Market Share
11.1.2. Regional/Sub-Regional Company Market Share
11.2. Company Profiles
11.2.1. Beckman Coulter
11.2.1.1. Business Overview
11.2.1.2. Products Offering
11.2.1.3. Financial Insights (Based on Availability)
11.2.1.4. Company Market Share Analysis
11.2.1.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.1.6. Strategy
11.2.1.7. SWOT Analysis
11.2.2. EMD Millipore
11.2.2.1. Business Overview
11.2.2.2. Products Offering
11.2.2.3. Financial Insights (Based on Availability)
11.2.2.4. Company Market Share Analysis
11.2.2.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.2.6. Strategy
11.2.2.7. SWOT Analysis
11.2.3. Partec
11.2.3.1. Business Overview
11.2.3.2. Products Offering
11.2.3.3. Financial Insights (Based on Availability)
11.2.3.4. Company Market Share Analysis
11.2.3.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.3.6. Strategy
11.2.3.7. SWOT Analysis
11.2.4. Sony Biotechnology
11.2.4.1. Business Overview
11.2.4.2. Products Offering
11.2.4.3. Financial Insights (Based on Availability)
11.2.4.4. Company Market Share Analysis
11.2.4.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.4.6. Strategy
11.2.4.7. SWOT Analysis
11.2.5. Sysmex
11.2.5.1. Business Overview
11.2.5.2. Products Offering
11.2.5.3. Financial Insights (Based on Availability)
11.2.5.4. Company Market Share Analysis
11.2.5.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.5.6. Strategy
11.2.5.7. SWOT Analysis
11.2.6. MilliporeSigma
11.2.6.1. Business Overview
11.2.6.2. Products Offering
11.2.6.3. Financial Insights (Based on Availability)
11.2.6.4. Company Market Share Analysis
11.2.6.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.6.6. Strategy
11.2.6.7. SWOT Analysis
11.2.7. Guava Technologies
11.2.7.1. Business Overview
11.2.7.2. Products Offering
11.2.7.3. Financial Insights (Based on Availability)
11.2.7.4. Company Market Share Analysis
11.2.7.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.7.6. Strategy
11.2.7.7. SWOT Analysis
11.2.8. Cytomation
11.2.8.1. Business Overview
11.2.8.2. Products Offering
11.2.8.3. Financial Insights (Based on Availability)
11.2.8.4. Company Market Share Analysis
11.2.8.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.8.6. Strategy
11.2.8.7. SWOT Analysis
11.2.9. Stratedigm
11.2.9.1. Business Overview
11.2.9.2. Products Offering
11.2.9.3. Financial Insights (Based on Availability)
11.2.9.4. Company Market Share Analysis
11.2.9.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.9.6. Strategy
11.2.9.7. SWOT Analysis
11.2.10. Celsis In Vitro Technologies
11.2.10.1. Business Overview
11.2.10.2. Products Offering
11.2.10.3. Financial Insights (Based on Availability)
11.2.10.4. Company Market Share Analysis
11.2.10.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.10.6. Strategy
11.2.10.7. SWOT Analysis
11.2.11. Thermo Fisher Scientific
11.2.11.1. Business Overview
11.2.11.2. Products Offering
11.2.11.3. Financial Insights (Based on Availability)
11.2.11.4. Company Market Share Analysis
11.2.11.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.11.6. Strategy
11.2.11.7. SWOT Analysis
11.2.12. Acell Inc.
11.2.12.1. Business Overview
11.2.12.2. Products Offering
11.2.12.3. Financial Insights (Based on Availability)
11.2.12.4. Company Market Share Analysis
11.2.12.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.12.6. Strategy
11.2.12.7. SWOT Analysis
11.2.13. Velos Bio
11.2.13.1. Business Overview
11.2.13.2. Products Offering
11.2.13.3. Financial Insights (Based on Availability)
11.2.13.4. Company Market Share Analysis
11.2.13.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.13.6. Strategy
11.2.13.7. SWOT Analysis
11.2.14. BioRad Laboratories
11.2.14.1. Business Overview
11.2.14.2. Products Offering
11.2.14.3. Financial Insights (Based on Availability)
11.2.14.4. Company Market Share Analysis
11.2.14.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.14.6. Strategy
11.2.14.7. SWOT Analysis

List of Figures

List of Tables

Table 1: Global Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 2: Global Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 3: Global Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 4: Global Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Component, 2020-2035

Table 5: Global Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Region, 2020-2035

Table 6: North America Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 7: North America Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 8: North America Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 9: North America Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Component, 2020-2035

Table 10: North America Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Country, 2020-2035

Table 11: Europe Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 12: Europe Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 13: Europe Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 14: Europe Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Component, 2020-2035

Table 15: Europe Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 16: Asia Pacific Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 17: Asia Pacific Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 18: Asia Pacific Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 19: Asia Pacific Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Component, 2020-2035

Table 20: Asia Pacific Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 21: Latin America Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 22: Latin America Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 23: Latin America Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 24: Latin America Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Component, 2020-2035

Table 25: Latin America Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 26: Middle East & Africa Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 27: Middle East & Africa Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 28: Middle East & Africa Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 29: Middle East & Africa Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Component, 2020-2035

Table 30: Middle East & Africa Benchtop Automated Cell Sorter Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Frequently Asked Questions

Industry

Industrial Automation Equipment Market Research

Explore comprehensive market research reports covering all aspects of the Industrial Automation Equipment industry, including market size, growth trends, competitive landscape, and strategic insights.

View Industry Page
;